Annual Retained Earnings
-$109.08 M
-$7.68 M-7.57%
June 30, 2024
Summary
- As of February 20, 2025, INM annual retained earnings is -$109.08 million, with the most recent change of -$7.68 million (-7.57%) on June 30, 2024.
- During the last 3 years, INM annual retained earnings has fallen by -$34.22 million (-45.72%).
- INM annual retained earnings is now -1212.03% below its all-time high of -$8.31 million, reached on July 31, 2001.
Performance
INM Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$113.33 M
-$2.58 M-2.33%
December 31, 2024
Summary
- As of February 20, 2025, INM quarterly retained earnings is -$113.33 million, with the most recent change of -$2.58 million (-2.33%) on December 31, 2024.
- Over the past year, INM quarterly retained earnings has dropped by -$6.19 million (-5.78%).
- INM quarterly retained earnings is now -1193.74% below its all-time high of -$8.76 million, reached on October 31, 2001.
Performance
INM Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
INM Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.6% | -5.8% |
| 3 y3 years | -45.7% | -5.8% |
| 5 y5 years | -121.8% | -5.8% |
INM Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.7% | at low | -38.0% | at low |
| 5 y | 5-year | -121.8% | at low | -116.9% | at low |
| alltime | all time | -1212.0% | at low | -1193.7% | at low |
InMed Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -$113.33 M(+2.3%) |
| Sep 2024 | - | -$110.75 M(+1.5%) |
| Jun 2024 | -$109.08 M(+7.6%) | -$109.08 M(+1.8%) |
| Mar 2024 | - | -$107.14 M(+1.6%) |
| Dec 2023 | - | -$105.42 M(+1.4%) |
| Sep 2023 | - | -$103.94 M(+2.5%) |
| Jun 2023 | -$101.40 M(+8.5%) | -$101.40 M(+0.3%) |
| Mar 2023 | - | -$101.06 M(+2.0%) |
| Dec 2022 | - | -$99.06 M(+2.2%) |
| Sep 2022 | - | -$96.96 M(+3.8%) |
| Jun 2022 | -$93.45 M(+24.8%) | -$93.45 M(+9.2%) |
| Mar 2022 | - | -$85.58 M(+4.2%) |
| Dec 2021 | - | -$82.11 M(+5.5%) |
| Sep 2021 | - | -$77.82 M(+4.0%) |
| Jun 2021 | -$74.85 M(+15.8%) | -$74.85 M(+4.6%) |
| Mar 2021 | - | -$71.59 M(+4.5%) |
| Dec 2020 | - | -$68.49 M(+3.4%) |
| Sep 2020 | - | -$66.25 M(+2.5%) |
| Jun 2020 | -$64.65 M(+31.4%) | -$64.65 M(+23.7%) |
| Mar 2020 | - | -$52.26 M(-4.3%) |
| Dec 2019 | - | -$54.59 M(+5.6%) |
| Sep 2019 | - | -$51.71 M(+5.1%) |
| Jun 2019 | -$49.19 M(+26.1%) | -$49.19 M(+8.9%) |
| Mar 2019 | - | -$45.16 M(+8.3%) |
| Dec 2018 | - | -$41.71 M(-0.5%) |
| Sep 2018 | - | -$41.92 M(+7.4%) |
| Jun 2018 | -$39.02 M(+18.6%) | -$39.02 M(+4.4%) |
| Mar 2018 | - | -$37.39 M(+1.9%) |
| Dec 2017 | - | -$36.71 M(+2.1%) |
| Sep 2017 | - | -$35.96 M(+9.3%) |
| Jun 2017 | -$32.90 M(+11.1%) | -$32.90 M(+7.2%) |
| Mar 2017 | - | -$30.68 M(+3.9%) |
| Dec 2016 | - | -$29.52 M(+0.2%) |
| Sep 2016 | - | -$29.46 M(-0.5%) |
| Jun 2016 | -$29.62 M(+2.3%) | -$29.62 M(+1.7%) |
| Mar 2016 | - | -$29.13 M(+8.1%) |
| Dec 2015 | - | -$26.96 M(-1.2%) |
| Sep 2015 | - | -$27.29 M(-5.8%) |
| Jun 2015 | -$28.96 M(-2.4%) | -$28.96 M(+6.4%) |
| Mar 2015 | - | -$27.21 M(-3.9%) |
| Dec 2014 | - | -$28.31 M(-2.2%) |
| Sep 2014 | - | -$28.94 M(-2.4%) |
| Jun 2014 | -$29.67 M(+2.6%) | -$29.67 M(+7.3%) |
| Mar 2014 | - | -$27.66 M(-3.4%) |
| Dec 2013 | - | -$28.62 M(-3.0%) |
| Sep 2013 | - | -$29.50 M(+2.0%) |
| Jun 2013 | -$28.91 M | -$28.91 M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | -$29.88 M(-2.2%) |
| Dec 2012 | - | -$30.55 M(-1.1%) |
| Sep 2012 | - | -$30.88 M(+3.4%) |
| Jun 2012 | -$29.86 M(-4.2%) | -$29.86 M(-1.6%) |
| Mar 2012 | - | -$30.34 M(+2.4%) |
| Dec 2011 | - | -$29.63 M(+1.7%) |
| Sep 2011 | - | -$29.12 M(-6.5%) |
| Jun 2011 | -$31.16 M(+10.0%) | -$31.16 M(+0.4%) |
| Mar 2011 | - | -$31.04 M(+3.6%) |
| Dec 2010 | - | -$29.95 M(+3.3%) |
| Sep 2010 | - | -$29.00 M(+2.3%) |
| Jun 2010 | -$28.33 M(+11.5%) | -$28.33 M(-3.0%) |
| Mar 2010 | - | -$29.21 M(+3.0%) |
| Dec 2009 | - | -$28.35 M(+2.4%) |
| Sep 2009 | - | -$27.69 M(+8.9%) |
| Jun 2009 | -$25.42 M(-8.5%) | -$25.42 M(+7.9%) |
| Mar 2009 | - | -$23.55 M(-3.2%) |
| Dec 2008 | - | -$24.34 M(-12.1%) |
| Sep 2008 | - | -$27.68 M(-0.4%) |
| Jun 2008 | -$27.79 M(+8.2%) | -$27.79 M(+2.0%) |
| Mar 2008 | - | -$27.25 M(-3.7%) |
| Dec 2007 | - | -$28.30 M(+1.8%) |
| Sep 2007 | - | -$27.81 M(+8.3%) |
| Jun 2007 | -$25.68 M(+11.9%) | -$25.68 M(+25.0%) |
| Mar 2007 | - | -$20.54 M(+2.2%) |
| Dec 2006 | - | -$20.10 M(-13.3%) |
| Sep 2006 | - | -$23.20 M(+1.0%) |
| Jun 2006 | -$22.96 M(+16.4%) | -$22.96 M(+5.4%) |
| Mar 2006 | - | -$21.80 M(+1.7%) |
| Dec 2005 | - | -$21.43 M(+1.3%) |
| Sep 2005 | - | -$21.14 M(+7.2%) |
| Jun 2005 | -$19.73 M(+26.4%) | -$19.73 M(+6.1%) |
| Mar 2005 | - | -$18.59 M(+1.1%) |
| Dec 2004 | - | -$18.38 M(+7.1%) |
| Sep 2004 | - | -$17.16 M(+10.0%) |
| Jul 2004 | -$15.61 M(+16.9%) | -$15.61 M(+7.8%) |
| Apr 2004 | - | -$14.48 M(-1.7%) |
| Jan 2004 | - | -$14.73 M(+1.8%) |
| Oct 2003 | - | -$14.47 M(+8.5%) |
| Jul 2003 | -$13.35 M(+24.2%) | -$13.35 M(+5.2%) |
| Apr 2003 | - | -$12.69 M(+8.0%) |
| Jan 2003 | - | -$11.75 M(+4.8%) |
| Oct 2002 | - | -$11.22 M(+4.4%) |
| Jul 2002 | -$10.74 M(+29.2%) | -$10.74 M(+4.6%) |
| Apr 2002 | - | -$10.27 M(+8.2%) |
| Jan 2002 | - | -$9.50 M(+8.4%) |
| Oct 2001 | - | -$8.76 M |
| Jul 2001 | -$8.31 M | - |
FAQ
- What is InMed Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual retained earnings year-on-year change?
- What is InMed Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly retained earnings year-on-year change?
What is InMed Pharmaceuticals annual retained earnings?
The current annual retained earnings of INM is -$109.08 M
What is the all time high annual retained earnings for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual retained earnings is -$8.31 M
What is InMed Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, INM annual retained earnings has changed by -$7.68 M (-7.57%)
What is InMed Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of INM is -$113.33 M
What is the all time high quarterly retained earnings for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly retained earnings is -$8.76 M
What is InMed Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, INM quarterly retained earnings has changed by -$6.19 M (-5.78%)